BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BHR Pharma, LLC 

607 Herndon Parkway
Suite 110
Herndon  Virginia  20170  U.S.A.
Phone: 703-964-3033 Fax: 703-964-3044


SEARCH JOBS




Industry
Pharmaceutical






 Company News
BHR Pharma, LLC Announces SyNAPSe® Trial Completes Patient Enrollment 9/3/2013 10:41:49 AM
BHR Pharma, LLC Announces 1,000th Enrolled Patient in SyNAPSe® Trial 4/16/2013 9:33:29 AM
BHR Pharma, LLC Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation 2/14/2013 8:29:44 AM
BHR Pharma, LLC SyNAPSe® Trial DSMB Data Analyses Determine No Safety Issues; Study Should Continue to Conclusion 1/17/2013 9:54:57 AM
BHR Pharma, LLC SyNAPSe® Trial Reaches Enrollment Midpoint 7/25/2012 10:18:23 AM
BHR Pharma, LLC Expands SyNAPSe® Trial into Thailand, China and Russia 6/13/2012 9:52:15 AM
BHR Pharma, LLC's SyNAPSe(R) Trial Reaches Important Enrollment Milestone on Brain Injury Awareness Day 3/22/2012 9:10:26 AM
BHR Pharma, LLC Meets Critical Enrollment Milestone for Its SyNAPSe(R) Clinical Trial 9/7/2011 11:39:37 AM
BHR Pharma, LLC Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial 7/23/2010 9:21:25 AM